Global companion diagnostic market size was valued at USD3 billion in 2019 and projected to grow at an impressive CAGR during the forecast period. The key factor responsible for the growth of companion diagnostic market is growing cases of cancer across the globe. Additionally, increase in requirement for targeted therapy is another major factor which is anticipated to bode well for the growth of companion diagnostic market in the coming years. Moreover, rising number of clinical trials is further anticipated to bolster the market growth until 2025.

The global companion diagnostic market is segmented based on technology, products, indication, end-user, application, and region. Based on end user, the market can be segmented into pharmaceutical & biotechnology companies, research laboratories, contract research organization and others. Out of which, the pharmaceutical & biotechnology companies dominated the market in terms of largest market share until 2019 and is further anticipated to be the fastest-growing application segment in the companion diagnostic market during the next five years as well. This growth can be accredited to widespread use of companion diagnostics in such industries because of their increasing stronghold in drug development sector as well as growing importance of companion diagnostic biomarkers. Additionally, surge in requirement for personalized medicines coupled with high demand for targeted therapies for treatment of multiple diseases and disorders is further boosting the growth of the segment across the globe.

Major players operating in the global companion diagnostic market include NG Biotech, Agilent Technologies, Illumnia, Qiagen, Thermo Fisher Scientific, Roche, Molecular MD, Myriad Genetics, Foundation Medicine, Bayer, Genentech, Abbott, Novartis, Perkin Elmer, Luminex Corporation, Parexel, Quest Diagnostics, Genesys Diagnostics, Danaher, Siemens Healthcare, Biomerieux SA and others. The companies operating in global companion diagnostic market are focussing towards expanding their share in the market. For instance, these key players are making organic strategies such as new product launches & approvals, among others in order to enrich their consumer base. 

Years considered for this report:

Historical Years: 2015-2018                                                                         

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021–2025

Objective of the Study:

  • To analyse and forecast the market size of global companion diagnostic market.
  • To classify and forecast global companion diagnostic market based on technology, products, indication, end-user, application, company and regional distribution.
  • To identify drivers and challenges for global companion diagnostic market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global companion diagnostic market.
  • To conduct pricing analysis for global companion diagnostic market.
  • To identify and analyse the profile of leading players operating in global companion diagnostic market.


Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of hospitals/clinics across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the hospitals/clinics which could not be identified due to the limitations of secondary research. TechSci Research analyzed the new products, technologies and presence of all major players across the globe.

TechSci Research calculated the market size of global companion diagnostic market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.


Key Target Audience:

  • Companion diagnostic hospitals/clinics, research institutes and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to companion diagnostic  
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals/clinics and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global companion diagnostic market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Technology:
    • Nanostring Technology
    • Next-Generation sequencing
    • In-Situ Hybridization
    • Immunohistochemistry
    • Others
  • Market, By Products:
    • Devices
    • Kits
    • Assay
  • Market, By Indication:
    • Oncology
    • Respiratory
    • Orthopedics
    • Others
  • Market, By End-User:
    • Pharmaceutical & Biotechnology Companies
    • Research Laboratories
    • Contract research organization
    • Others
  • Market, By Application:
    • Drug Discovery
    • In-Vitro diagnostics
    • Others
  • Market, By Region:
    • North America
      • United States
      • Mexico
      • Canada
    • Europe
      • Germany
      • France
      • United Kingdom
      • Italy
      • Spain
    • Asia-Pacific
      • China
      • India 
      • Japan
      • South Korea
      • Australia
    • Middle East and Africa
      • South Africa
      • Saudi Arabia
      • UAE
    • South America
      • Brazil
      • Argentina
      • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global companion diagnostic market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
It is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com  

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Product Overview

2.    Research Methodology

3.    Executive Summary

4.    Global Companion Diagnostic Market Outlook

4.1.  Market Size & Forecast

4.1.1.     By Value & Volume

4.2.  Market Share & Forecast

4.2.1.     By Technology (Nanostring Technology, Next-Generation sequencing, In-Situ Hybridization, Immunohistochemistry and Others)

4.2.2.     By Products (Devices, Kits and assay)

4.2.3.     By Indication (Oncology, Respiratory, Orthopedics and Others)

4.2.4.     By End-User (Pharmaceutical & Biotechnology Companies, Research Laboratories, Contract research organization and others)

4.2.5.     By Application (Drug Discovery, In-Vitro diagnostics and Others)

4.2.6.     By Company (2019)

4.2.7.     By Region

4.3.  Market Attractiveness Index

5.    Asia-Pacific Companion Diagnostic Market Outlook

5.1.  Market Size & Forecast          

5.1.1.     By Value & Volume

5.2.  Market Share & Forecast

5.2.1.     By Technology

5.2.2.     By Products

5.2.3.     By Indication

5.2.4.     By End-User

5.2.5.     By Application

5.2.6.     By Country

5.3.  Market Attractiveness Index

5.4.  Asia-Pacific: Country Analysis

5.4.1.     China Companion Diagnostic Market Outlook

5.4.1.1.         Market Size & Forecast

5.4.1.1.1.             By Value

5.4.1.2.         Market Share & Forecast

5.4.1.2.1.             By Technology

5.4.1.2.2.             By Products

5.4.1.2.3.             By Indication

5.4.1.2.4.             By End-User

5.4.1.2.5.             By Application

5.4.2.     India Companion Diagnostic Market Outlook

5.4.2.1.         Market Size & Forecast

5.4.2.1.1.             By Value

5.4.2.2.         Market Share & Forecast

5.4.2.2.1.             By Technology

5.4.2.2.2.             By Products

5.4.2.2.3.             By Indication

5.4.2.2.4.             By End-User

5.4.2.2.5.             By Application

5.4.3.     Japan Companion Diagnostic Market Outlook

5.4.3.1.         Market Size & Forecast

5.4.3.1.1.             By Value

5.4.3.2.         Market Share & Forecast

5.4.3.2.1.             By Technology

5.4.3.2.2.             By Products

5.4.3.2.3.             By Indication

5.4.3.2.4.             By End-User

5.4.3.2.5.             By Application

5.4.4.     South Korea Companion Diagnostic Market Outlook

5.4.4.1.         Market Size & Forecast

5.4.4.1.1.             By Value

5.4.4.2.         Market Share & Forecast

5.4.4.2.1.             By Technology

5.4.4.2.2.             By Products

5.4.4.2.3.             By Indication

5.4.4.2.4.             By End-User

5.4.4.2.5.             By Application

5.4.5.     Singapore Companion Diagnostic Market Outlook

5.4.5.1.         Market Size & Forecast

5.4.5.1.1.             By Value

5.4.5.2.         Market Share & Forecast

5.4.5.2.1.             By Technology

5.4.5.2.2.             By Products

5.4.5.2.3.             By Indication

5.4.5.2.4.             By End-User

5.4.5.2.5.             By Application

5.4.6.     Australia Companion Diagnostic Market Outlook

5.4.6.1.         Market Size & Forecast

5.4.6.1.1.             By Value

5.4.6.2.         Market Share & Forecast

5.4.6.2.1.             By Technology

5.4.6.2.2.             By Products

5.4.6.2.3.             By Indication

5.4.6.2.4.             By End-User

5.4.6.2.5.             By Application

6.    Europe Companion Diagnostic Market Outlook

6.1.  Market Size & Forecast          

6.1.1.     By Value & Volume

6.2.  Market Share & Forecast

6.2.1.     By Technology

6.2.2.     By Products

6.2.3.     By Indication

6.2.4.     By End-User

6.2.5.     By Application

6.2.6.     By Country

6.3.  Market Attractiveness Index

6.4.  Europe: Country Analysis

6.4.1.     France Companion Diagnostic Market Outlook

6.4.1.1.         Market Size & Forecast

6.4.1.1.1.             By Value

6.4.1.2.         Market Share & Forecast

6.4.1.2.1.             By Technology

6.4.1.2.2.             By Products

6.4.1.2.3.             By Indication

6.4.1.2.4.             By End-User

6.4.1.2.5.             By Application

6.4.2.     Germany Companion Diagnostic Market Outlook

6.4.2.1.         Market Size & Forecast

6.4.2.1.1.             By Value

6.4.2.2.         Market Share & Forecast

6.4.2.2.1.             By Technology

6.4.2.2.2.             By Products

6.4.2.2.3.             By Indication

6.4.2.2.4.             By End-User

6.4.2.2.5.             By Application

6.4.3.     United Kingdom Companion Diagnostic Market Outlook

6.4.3.1.         Market Size & Forecast

6.4.3.1.1.             By Value

6.4.3.2.         Market Share & Forecast

6.4.3.2.1.             By Technology

6.4.3.2.2.             By Products

6.4.3.2.3.             By Indication

6.4.3.2.4.             By End-User

6.4.3.2.5.             By Application

6.4.4.     Italy Companion Diagnostic Market Outlook

6.4.4.1.         Market Size & Forecast

6.4.4.1.1.             By Value

6.4.4.2.         Market Share & Forecast

6.4.4.2.1.             By Technology

6.4.4.2.2.             By Products

6.4.4.2.3.             By Indication

6.4.4.2.4.             By End-User

6.4.4.2.5.             By Application

7.    North America Companion Diagnostic Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Technology

7.2.2.     By Products

7.2.3.     By Indication

7.2.4.     By End-User

7.2.5.     By Application

7.2.6.     By Country

7.3.  Market Attractiveness Index

7.4.  North America: Country Analysis

7.4.1.     United States Companion Diagnostic Market Outlook

7.4.1.1.         Market Size & Forecast

7.4.1.1.1.             By Value

7.4.1.2.         Market Share & Forecast

7.4.1.2.1.             By Technology

7.4.1.2.2.             By Products

7.4.1.2.3.             By Indication

7.4.1.2.4.             By End-User

7.4.1.2.5.             By Application

7.4.2.     Mexico Companion Diagnostic Market Outlook

7.4.2.1.         Market Size & Forecast

7.4.2.1.1.             By Value

7.4.2.2.         Market Share & Forecast

7.4.2.2.1.             By Technology

7.4.2.2.2.             By Products

7.4.2.2.3.             By Indication

7.4.2.2.4.             By End-User

7.4.2.2.5.             By Application

7.4.3.     Canada Companion Diagnostic Market Outlook

7.4.3.1.         Market Size & Forecast

7.4.3.1.1.             By Value

7.4.3.2.         Market Share & Forecast

7.4.3.2.1.             By Technology

7.4.3.2.2.             By Products

7.4.3.2.3.             By Indication

7.4.3.2.4.             By End-User

7.4.3.2.5.             By Application

8.    South America Companion Diagnostic Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value & Volume

8.2.  Market Share & Forecast

8.2.1.     By Technology

8.2.2.     By Products

8.2.3.     By Indication

8.2.4.     By End-User

8.2.5.     By Application

8.2.6.     By Country

8.3.  Market Attractiveness Index

8.4.  South America: Country Analysis

8.4.1.     Brazil Companion Diagnostic Market Outlook

8.4.1.1.         Market Size & Forecast

8.4.1.1.1.             By Value

8.4.1.2.         Market Share & Forecast

8.4.1.2.1.             By Technology

8.4.1.2.2.             By Products

8.4.1.2.3.             By Indication

8.4.1.2.4.             By End-User

8.4.1.2.5.             By Application

8.4.2.     Argentina Companion Diagnostic Market Outlook

8.4.2.1.         Market Size & Forecast

8.4.2.1.1.             By Value

8.4.2.2.         Market Share & Forecast

8.4.2.2.1.             By Technology

8.4.2.2.2.             By Products

8.4.2.2.3.             By Indication

8.4.2.2.4.             By End-User

8.4.2.2.5.             By Application

8.4.3.     Colombia Companion Diagnostic Market Outlook

8.4.3.1.         Market Size & Forecast

8.4.3.1.1.             By Value

8.4.3.2.         Market Share & Forecast

8.4.3.2.1.             By Technology

8.4.3.2.2.             By Products

8.4.3.2.3.             By Indication

8.4.3.2.4.             By End-User

8.4.3.2.5.             By Application

9.    Middle East and Africa Companion Diagnostic Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value & Volume

9.2.  Market Share & Forecast

9.2.1.     By Technology

9.2.2.     By Products

9.2.3.     By Indication

9.2.4.     By End-User

9.2.5.     By Application

9.2.6.     By Country

9.3.  Market Attractiveness Index

9.4.  MEA: Country Analysis

9.4.1.     South Africa Companion Diagnostic Market Outlook

9.4.1.1.         Market Size & Forecast

9.4.1.1.1.             By Value

9.4.1.2.         Market Share & Forecast

9.4.1.2.1.             By Technology

9.4.1.2.2.             By Products

9.4.1.2.3.             By Indication

9.4.1.2.4.             By End-User

9.4.1.2.5.             By Application

9.4.2.     Saudi Arabia Companion Diagnostic Market Outlook

9.4.2.1.         Market Size & Forecast

9.4.2.1.1.             By Value

9.4.2.2.         Market Share & Forecast

9.4.2.2.1.             By Technology

9.4.2.2.2.             By Products

9.4.2.2.3.             By Indication

9.4.2.2.4.             By End-User

9.4.2.2.5.             By Application

9.4.3.     UAE Companion Diagnostic Market Outlook

9.4.3.1.         Market Size & Forecast

9.4.3.1.1.             By Value

9.4.3.2.         Market Share & Forecast

9.4.3.2.1.             By Technology

9.4.3.2.2.             By Products

9.4.3.2.3.             By Indication

9.4.3.2.4.             By End-User

9.4.3.2.5.             By Application

10.  Market Dynamics

10.1.              Drivers

10.2.              Challenges

11.  Market Trends & Developments

12.  Competitive Landscape

12.1.              Competition Outlook

12.2.              Players Profiled (Leading Companies)

12.2.1.  NG Biotech

12.2.2.  Agilent Technologies

12.2.3.  Illumnia

12.2.4.  Qiagen

12.2.5.  Thermo Fisher Scientific

12.2.6.   Roche

12.2.7.  Molecular MD

12.2.8.  Myriad Genetics

12.2.9.  Foundation Medicine

12.2.10.Bayer

12.2.11.Genentech

12.2.12.Abbott

12.2.13.Novartis

12.2.14.Perkin Elmer

12.2.15.Luminex Corporation

12.2.16.Parexel

12.2.17.Quest Diagnostics

12.2.18.Genesys Diagnostics

12.2.19.Danaher

12.2.20.Siemens Healthcare

12.2.21.Biomerieux SA

13.  Strategic Recommendations

About Us & Disclaimer

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com